Drug Alert, March 19, 2015 by unknown
MARCH 19, 2015 
IOWA GOVERNOR ’S OFFICE OF DRUG CONTROL POLICY 
DRUG ALERT 
· PREVENTION · TREATMENT · ENFORCEMENT ·  1 
 
DEA has also issued warnings to law enforce-
ment as fentanyl can be absorbed through the 
skin and accidental inhalation of airborne 
powder can also occur. DEA is concerned 
about law enforcement coming in contact 
with fentanyl on the streets during the 
course of enforcement, such as a buy-walk, 
or buy-bust operation. 
Historically, this is not the first time fentanyl 
has posed such a threat to public health and 
safety. Between 2005 and 2007, over 1,000 
U.S. deaths were attributed to fentanyl – 
many of which occurred in Chicago, Detroit, 
and Philadelphia. The source of that fentanyl 
was traced to a single lab in Mexico. When 
that lab was identified and dismantled, the 
surge ended. 
The current outbreak involves not just fenta-
nyl, but also fentanyl analogues.  The current 
outbreak is wider geographically and in-
volves a wide array of individuals including 
new and experiences abusers. 
Source: United States Drug Enforcement 
Administration (DEA) 
The United States Drug Enforcement Ad-
ministration (DEA) issued a nationwide alert 
about the dangers of fentanyl and fentanyl 
analogues/compounds. Fentanyl is com-
monly laced in heroin, causing significant 
problems across the country, particularly as 
heroin abuse has increased. This alert was 
issued through the multi-agency El Paso 
Intelligence Center (EPIC) to all U.S. law 
enforcement. 
“Drug incidents and overdoses related to 
fentanyl are occurring at an alarming rate 
throughout the United States and represent a 
significant threat to public health and safety,” 
said DEA Administrator Michele M. Leon-
hart. “Often laced in heroin, fentanyl and 
fentanyl analogues produced in illicit clan-
destine labs are up to 100 times more pow-
erful than morphine and 30-50 times more 
powerful than heroin.  Fentanyl is extremely 
dangerous to law enforcement and anyone 
else who may come into contact with it. 
DEA will continue to address this threat by 
directly attacking the drug trafficking net-
works producing and importing these deadly 
drugs.   
We have lost too many Americans to drug 
overdoses and we strongly encourage parents, 
caregivers, teachers, local law enforcement 
and mentors to firmly and passionately edu-
cate others about the dangers of drug abuse, 
and to seek immediate help and treatment for 
those addicted to drugs.” 
In the last two years, DEA has seen a signifi-
cant resurgence in fentanyl-related seizures. 
According to the National Forensic Laborato-
ry Information System (NFLIS), state and 
local labs reported 3,344 fentanyl submissions 
in 2014, up from 942 in 2013.  In addition, 
DEA has identified 15 other fentanyl-related 
compounds. 
Fentanyl is a Schedule II narcotic used as an 
analgesic and anesthetic. It is the most potent 
opioid available for use in medical treatment 
– 50 to 100 times more potent than mor-
phine and 30 to 50 times more potent than 
heroin. Fentanyl is potentially lethal, even at 
very low levels. Ingestion of small doses as 
small as 0.25 mg can be fatal. Its euphoric 
effects are indistinguishable from morphine or 
heroin. 
DEA ISSUES ALERT ON FENTANYL-LACED HEROIN 
RECENT EXAMPLES 
 New Hampshire State Laboratory recently reported four fentanyl 
overdose deaths within a two-month period. 
 New Jersey saw a huge spike in fentanyl deaths in 2014, reporting 
as many as 80 in the first six months of the fiscal year. 
 Rhode Island and Pennsylvania have also seen huge increases since 
2013. In a 15-month period, about 200 deaths were reported in 
Pennsylvania related to fentanyl. 
 In the St. Louis area, based on information provided by medical 
examiners over a 10-year period, fentanyl was the only drug at-
tributed as a primary death factor in 44 percent of overdose cases. 
 In June 2014, DEA New York dismantled a heroin and fentanyl 
network and arrested the two heads of the organization. These 
individuals were linked to at least three overdose deaths from hero-
in and fentanyl they sold. 
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